Skip to content
Agentic OS
Menu

Intelligence / Healthtech / PMA Approvals

ApprovalsLIVEUpdated 18 Nov 2026

PMA Approvals

Class III medical devices FDA approved or changed through premarket approval, and who makes them.

Sources: openFDA device PMA · Rebuilt weekly · Class III devices approved by FDA: original approvals and supplements that change the device (180-day, panel-track and special tracks). 30-day manufacturing notices are left out.

Approvals
120
in the 90 days to 2026-11-18
Added in 30 days
35
to 18 Nov 2026
Top specialty
Cardiovascular
53 · 44% of the list
Approval type covered
5
distinct values
Snapshot · 18 Nov 2026
Explore all 120

Signals

What the register says this week, and why it matters if you sell into it.

  1. Cardiovascular leads with 53 of 120, then Pathology (15).
  2. 35 added in the 30 days to 18 Nov 2026.
  3. Latest: Baxter Healthcare Corporation, PerClot Absorbable Hemostatic Powder Accessory Tips (supplement (normal 180 day track no user fee)).
  4. A PMA approval is a high-risk device launch: reimbursement, distribution, clinical training and sales hires follow.

Export the full pma approvals

120 rows as a .csv. Free. Every field, with its source link.

Specialty 1
Approval type
15 / 120 approvals
DecidedCompanyDeviceSpecialtyType
4 Nov 2026RochePeasanton, CARoche cobas® EGFR Mutation Test, v2.0PathologySupplement (Special (Immediate Track))4 Nov 2026Roche Molecular Systems, INC.Pleasanton, CARoche cobas® KRAS Mutation TestPathologySupplement (Special (Immediate Track))4 Nov 2026Roche Molecular Systems, INC.Pleasanton, CARoche cobas® BRAF V600 Mutation TestPathologySupplement (Special (Immediate Track))23 Oct 2026Ventana Medical Systems, INC. (Roche Tissue Diagnostics)Tucson, AZVENTANA MET (SP44) RxDx AssayPathologySupplement (Normal 180 Day Track No User Fee)8 Oct 2026Ventana Medical SystemsTucson, AZVENTANA MMR RxDx PanelPathologySupplement (Normal 180 Day Track)8 Oct 2026Ventana Medical Systems, INC. (Roche Tissue Diagnostics)Tucson, AZVENTANA MMR RxDx PanelPathologySupplement (Normal 180 Day Track)18 Sept 2026Guardant Health, INC.Redwood City, CAGuardant360 CDxPathologySupplement (Normal 180 Day Track)16 Sept 2026Foundation Medicine, INC.Boston, MAFoundationOne CDxPathologySupplement (Normal 180 Day Track No User Fee)15 Sept 2026Agilent Technologies, INC.Carpinteria, CAMAGE-A4 IHC 1F9 pharmDxPathologySupplement (Normal 180 Day Track)9 Sept 2026Life Technologies CorporationFrederick, MDOncomine™ Dx Express TestPathologySupplement (Panel Track)4 Sept 2026Guardant Health, INC.Redwood City, CAGuardant360® CDxPathologySupplement (Normal 180 Day Track)2 Sept 2026Tempus Ai, INC.Chicago, ILxT CDxPathologySupplement (Normal 180 Day Track)27 Aug 2026Geneoscopy, INC.St. Louis, MOColoSense®PathologySupplement (Normal 180 Day Track)25 Aug 2026Ventana Medical Systems, INC.Tucson, AZVENTANA HER2 Dual ISH DNA Probe CocktailPathologySupplement (Panel Track)25 Aug 2026Ventana Medical Systems, INC.Tucson, AZPATHWAY anti-HER-2/neu (4B5) Rabbit Monoclonal Primary AntibodyPathologySupplement (Panel Track)

// How AOS uses this

Every row here is a potential account. AOS finds the ones that need what you sell, maps the decision makers and prepares the outreach for your approval.